Dr Ilaria Bernabei and the SULFISCON founders published this review which details the mechanisms leading to pathological calcification in cartilage and its role in osteoarthritis in Nature Reviews Rheumatology.
DOI. 10.1038/s41584-022-00875-4
News
Latest publication linking pathologic calcification with osteoarthritis
| 30 January 2023
Research of CSE's role in cartilage calcification published
| 8 September 2021
Dr Sonia Nasi published her findings on the role of CSE in pathologic cartilage and tendon calcification and how a CSE activator can prevent this. Her article appeared in the journal Antioxidants.
The article is open access https://www.mdpi.com/2076-3921/10/9/1433/pd
Innosuisse application
| 22 July 2021
Innosuisse accepted SULFISCON's application to support the development of an allosteric modulator of CSE as a treatment of pathologic calcification disorders
SULFISCON selected for BIOPOLE STARTUP FUND
On the 5th July 2023, BIOPOLE announced that it has selected SULFISCON for its BIOPOLE STARTUP FUND award, worth 45k CHF in the first year. This will help SULFISCON develop its medicinal chemistry program and support its ongoing research
2024 © |
Login
Création site Internet